These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 19002053)

  • 1. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C.
    Frenzel T; Lengsfeld P; Schirmer H; Hütter J; Weinmann HJ
    Invest Radiol; 2008 Dec; 43(12):817-28. PubMed ID: 19002053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.
    Pietsch H; Lengsfeld P; Steger-Hartmann T; Löwe A; Frenzel T; Hütter J; Sieber MA
    Invest Radiol; 2009 Apr; 44(4):226-33. PubMed ID: 19252439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-containing MRI contrast agents: important variations on a theme for NSF.
    Kuo PH
    J Am Coll Radiol; 2008 Jan; 5(1):29-35. PubMed ID: 18180006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular gadolinium contrast agents: differences in stability.
    Morcos SK
    Eur J Radiol; 2008 May; 66(2):175-9. PubMed ID: 18343072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speciation analysis of gadolinium-based MRI contrast agents in blood plasma by hydrophilic interaction chromatography/electrospray mass spectrometry.
    Künnemeyer J; Terborg L; Nowak S; Scheffer A; Telgmann L; Tokmak F; Günsel A; Wiesmüller G; Reichelt S; Karst U
    Anal Chem; 2008 Nov; 80(21):8163-70. PubMed ID: 18821778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI contrast agents: basic chemistry and safety.
    Hao D; Ai T; Goerner F; Hu X; Runge VM; Tweedle M
    J Magn Reson Imaging; 2012 Nov; 36(5):1060-71. PubMed ID: 23090917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
    Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
    Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.
    Port M; Idée JM; Medina C; Robic C; Sabatou M; Corot C
    Biometals; 2008 Aug; 21(4):469-90. PubMed ID: 18344005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and complexation properties of DTPA-N,N''-bis[bis(n-butyl)]-N'-methyl-tris(amide). Kinetic stability and water exchange of its Gd3+ complex.
    Jaszberényi Z; Tóth E; Kálai T; Király R; Burai L; Brücher E; Merbach AE; Hideg K
    Dalton Trans; 2005 Feb; (4):694-701. PubMed ID: 15702179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts.
    Varani J; DaSilva M; Warner RL; Deming MO; Barron AG; Johnson KJ; Swartz RD
    Invest Radiol; 2009 Feb; 44(2):74-81. PubMed ID: 19077912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stability of gadolinium-based contrast agents in human serum: A reanalysis of literature data and association with clinical outcomes.
    Prybylski JP; Semelka RC; Jay M
    Magn Reson Imaging; 2017 May; 38():145-151. PubMed ID: 28089499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nephrogenic systemic fibrosis].
    Breitschaft A; Stahlmann R
    Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenic systemic fibrosis: more questions and some answers.
    Morcos SK; Thomsen HS
    Nephron Clin Pract; 2008; 110(1):c24-31; discussion c32. PubMed ID: 18688172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speciation Analysis of Gadolinium in the Water-Insoluble Rat Brain Fraction After Administration of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2021 Sep; 56(9):535-544. PubMed ID: 33813574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
    Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability, water exchange, and anion binding studies on lanthanide(III) complexes with a macrocyclic ligand based on 1,7-diaza-12-crown-4: extremely fast water exchange on the Gd3+ complex.
    Pálinkás Z; Roca-Sabio A; Mato-Iglesias M; Esteban-Gómez D; Platas-Iglesias C; de Blas A; Rodríguez-Blas T; Tóth E
    Inorg Chem; 2009 Sep; 48(18):8878-89. PubMed ID: 19655713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure of Macrophages to Low-Dose Gadolinium-Based Contrast Medium: Impact on Oxidative Stress and Cytokines Production.
    Weng TI; Chen HJ; Lu CW; Ho YC; Wu JL; Liu SH; Hsiao JK
    Contrast Media Mol Imaging; 2018; 2018():3535769. PubMed ID: 30627059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.
    Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM
    Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.